| Titolo |
Pubblicato in |
Anno |
| Fibrosis-4 (FIB-4) index and mortality in COVID-19 patients admitted to the emergency department |
INTERNAL AND EMERGENCY MEDICINE |
2022 |
| Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF). a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study |
THE LANCET |
2022 |
| Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysis |
INTERNAL AND EMERGENCY MEDICINE |
2022 |
| Relation of Atrial Fibrillation to Angiographic Characteristics and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention |
THE AMERICAN JOURNAL OF CARDIOLOGY |
2021 |
| Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study |
CANCER |
2021 |
| Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study |
INTERNAL AND EMERGENCY MEDICINE |
2021 |
| Sex-based difference in anticoagulated patients with mechanical prosthetic heart valves and long-term mortality risk |
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE |
2021 |
| Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a network metanalysis on 605,771 patients |
EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY |
2021 |
| Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants |
MAYO CLINIC PROCEEDINGS |
2021 |
| Comparison of Anticoagulation Quality between Acenocoumarol and Warfarin in Patients with Mechanical Prosthetic Heart Valves: Insights from the Nationwide PLECTRUM Study |
MOLECULES |
2021 |
| Cancer and atrial fibrillation. epidemiology, mechanisms, and anticoagulation treatment |
PROGRESS IN CARDIOVASCULAR DISEASES |
2021 |
| A systematic review and a meta-analysis comparing prophylactic and therapeutic low molecular weight heparins for mortality reduction in 32,688 COVID-19 patients |
FRONTIERS IN PHARMACOLOGY |
2021 |
| Use of direct oral anticoagulants in patients with antiphospholipid syndrome. a systematic review and comparison of the international guidelines |
FRONTIERS IN CARDIOVASCULAR MEDICINE |
2021 |
| Circulating lipopolysaccharides and impaired antioxidant status in patients with atrial fibrillation. data from the athero-af study |
FRONTIERS IN CARDIOVASCULAR MEDICINE |
2021 |
| Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes. insights from the START-ANTIPLATELET registry |
INTERNATIONAL JOURNAL OF CARDIOLOGY |
2021 |
| Serum albumin, clotting activation and COVID-19 severity: a systematic review and meta-regression analysis of 4579 patients |
ITALIAN JOURNAL OF EMERGENCY MEDICINE |
2021 |
| Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. the nationwide PLECTRUM study |
BRITISH JOURNAL OF HAEMATOLOGY |
2020 |
| Seronegative antiphospholipid syndrome: Refining the value of “non-criteria” antibodies for diagnosis and clinical management |
HAEMATOLOGICA |
2020 |
| Serum albumin and risk of cardiovascular events in primary and secondary prevention: a systematic review of observational studies and Bayesian meta-regression analysis |
INTERNAL AND EMERGENCY MEDICINE |
2020 |
| Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation. a multicentre cohort study |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
2020 |
